A recent study published in the Frontiers in Endocrinology journal showed that heart failure with preserved ejection fraction ...
However, the authors note that the pathway "now places increased emphasis on establishing all four pillars of guideline-directed medical therapy (GDMT) for HFrEF in the hospital, when possible, along ...
Patients who have heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and high body mass index ...
A robust and systematic approach is key to ensuring that people living with heart failure with preserved ejection fraction (HFpEF) receive a timely and accurate diagnosis and guideline-based ...
randomized-withdrawal study involving participants with HFrEF (NYHA II–IV; left ventricular ejection fraction ≤40%). The participants were receiving optimal guideline-directed therapy, excluding ...
The device targets an estimated $3.7 billion market for HFrEF treatment, a significant opportunity that has piqued the interest of analysts and investors alike. The company has demonstrated strong ...
The device targets an estimated $3.7 billion market for HFrEF treatment, a significant opportunity that has piqued the interest of analysts and investors alike. The company has demonstrated strong ...
Heart Failure, Pathophysiology, Etiology, Reduced Ejection Fraction, Preserved Ejection Fraction, Revascularization, CABG, ...
CHICAGO, IL—A novel noninvasive intracardiac pressure monitoring device powered by artificial intelligence (AI) could be a potential alternative to invasive monitoring in patients with heart failure ...
In a new study, the drug, deucravacitinib, proved to be a safe and more effective treatment for cutaneous lupus erythematosus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback